Ono Pharmaceutical Co., Ltd.
OPHLY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.64B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $6.64 Billion |
|---|---|
| Enterprise Value | $-95,061,348,700.00 |
| Annual dividend | $0.14 |
| Dividend yield | 3.20% |
| Earnings per Share | $52.73 |
| Beta | 0.14 |
| Outstanding Shares | 1,409,730,000 |
Return
| Return on Equity | 8.68% |
|---|---|
| Return on Assets | 6.94% |
| Return on Invested Capital | 11.46% |
Valuation & Multiples
| P/E Ratio | 15.4 |
|---|---|
| PEG | -193.84 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 2.18 |
| Enterprise Value to EBIT | 9.91 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 29, 2026
EPS Estimate
$0.09
Consensus analyst estimateRevenue Estimate
$722.72 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 1, 2027
EPS Estimate
$0.10
Consensus analyst estimateRevenue Estimate
$770.60 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.01%▲ 0.00% |
|---|---|
| Total Invested | $363,096▼ 6.22% |
| Investors Holding | 60% |
About Ono Pharmaceutical Co., Ltd.
4,206 employees
CEO: Gyo Sagara
Ono Pharmaceutical Co., Ltd., along with its affiliated companies, is engaged in the global development, manufacturing, procurement, and sale of a diverse range of pharmaceutical products and diagnostic tools. Its diverse oncology portfo...